1.Correlation analysis of HMGB1 and MCP-1 levels and prognosis of patients with sepsis combined with AKI
Man NI ; Jun GE ; Ziang KONG
Tianjin Medical Journal 2025;53(3):297-301
Objective To analyze the correlation between the levels of high mobility group protein B1(HMGB1),monocyte chemotactic protein-1(MCP-1)and the prognosis of patients with sepsis combined with acute kidney injury(AKI).Methods A total of 100 patients with sepsis combined with AKI treated with continuous renal replacement therapy(CRRT)were included in this study and clinical data before treatment were collected.The levels of HMGB1 and MCP-1 were detected by enzyme-linked immunosorbent assay before and after CRRT treatment.Follow-up began on the day after the end of CRRT treatment,and the end point of follow-up was death or survival within 30 days.Patients were divided into the death group(31 cases)and the survival group(69 cases)according to survival status.Cox regression was used to analyze the relationship between HMGB1 and MCP-1 and death within 30 days after CRRT in patients with septic AKI.Receiver operating characteristics(ROC)curve was used to analyze the prognostic value of HMGB1 and MCP-1 in patients with sepsis combined with AKI after CRRT.Resluts The sequential organ failure(SOFA)scores,acute physiology and chronic healthⅡ(APACHE Ⅱ)scores were lower in the survival group than those in the death group(P<0.05).After CRRT treatment,HMGB1 and MCP-1 levels were lower in the survival group than those in the death group(P<0.05).Cox regression analysis showed that SOFA score,APACHE Ⅱscore,HMGB1 and MCP-1 increase after treatment were risk factors for death in patients with sepsis complicated with AKI.ROC curve analysis showed that the AUC of SOFA score,APACHE Ⅱ score,combined diagnosis of HMGB1 and MCP-1 after treatment was 0.973,which was significantly higher than that of single detection(P<0.05).Conclusion The increased levels of HMGB1 and MCP-1 in peripheral blood after treatment are independent risk factors for 30-day death in patients with sepsis complicated with AKI after CRRT treatment,and the combined prognostic value is high.
2.Analysis of erectile dysfunction and its associated factors in male patients undergoing peritoneal dialysis
Xiaohui XU ; Man ZHANG ; Tingting ZHOU ; Juan NI
National Journal of Andrology 2025;31(10):915-920
Objective To investigate the prevalence proportion and influencing factors of erectile dysfunction in male patients receiving peritoneal dialysis(PD),and to provide a basis for clinical intervention.Methods A total of 170 male patients undergoing maintenance PD in Jinling Hospital from January to June 2025 were selected as the study subjects.And the international erectile function index-5 was used to evaluate sexual function of the patients.The general data,dialy-sis adequacy,nutritional status and other clinical indicators were collected.The logistic regression analysis was used to identify the influence factors of erectile dysfunction in the patients with PD.Results The incidence of erectile dysfunction in male patients with PD was 45.3%.And univariate analysis showed that age,education level,smoking history,dialysis-related symptoms and depressive status were significantly correlated with erectile dysfunction in male patients(all P<0.05).Ordered logistic regression analysis identified age,sleep duration,smoking history,albumin and total cholesterol as independent risk factors for erectile dysfunction in male patients with PD.Conclusion The incidence of erectile dys-function is relatively high in male patients with PD which is influenced by various physiological and psychological factors.Clinically,attention should be paid to patients' nutritional status,sleep quality,and other factors,with comprehensive in-terventions implemented to improve sexual function and overall quality of life.
3.Development and application of quick response code for prediction of healthcare-associated infection risks in ICU inpatients
Man ZHANG ; Yongsheng LIANG ; Huai YANG ; Jiangnan SUN ; Xi WANG ; Zidi XU ; Jie SONG ; Yanli ZHANG ; Di ZHAO ; Rui WANG ; Chengsong ZHAO ; Xin NI
Chinese Journal of Infection Control 2025;24(9):1259-1268
Objective To identify high-risk factors for healthcare-associated infection(HAI)in patients in inten-sive care units(ICUs),and develop a quick response(QR)code-based APP prediction tool.Methods Information of inpatients in general ICUs of three hospitals in Guizhou Province from January to December 2024 were collected.Risk factors were analyzed with a logistic regression model.QR code-based APP was constructed and validated.Results A total of 1 782 patients in general ICUs of three hospitals in Guizhou Province in 2024 were included in the analysis,out of which 410 were HAI cases,and the incidence of HAI was 23.01%.Multivariate logistic regre-ssion analysis results of HAI in ICU inpatients showed that regional gross domestic product(GDP)≥58 685 Yuan,performing pathogen culture during this hospitalization,history of diabetes mellitus,history of cancer,length of hospital stay ≥7 days before infection,and duration of persistent fever>5 days before infection were independent risk factors for HAI in ICU patients(all P<0.05).The discrimination of the model(area under the receiver operating characteristic curve[AUC]of 0.841),calibration(Brier score of 0.129),and clinical effectiveness(net benefit of 11.4%when the risk threshold was 5%-74%)all performed well.Conclusion The QR code-based APP prediction tool is of great significance for scientific research transformation and precise HAI control.
4.Expert consensus on holistic integrative management of oropharyngeal squamous cell carcinoma
Moyi SUN ; Zongxuan HE ; Qianwei NI ; Xiaoying LI ; Lin KONG ; Qing XI ; Wei GUO ; Zhangui TANG ; Guoxin REN ; Zhijun SUN ; Jian MENG ; Jie ZHANG ; Jichen LI ; Yue HE ; Chunjie LI ; Lizheng QIN ; Kai YANG ; Bing HAN ; Yan SUN ; Haijun LU ; Xiaohong ZHAN ; Dapeng HAO ; Kai SONG ; Haoyue XU ; Lingxue BU ; Jieying LI ; Man HU ; Mingjin XU ; Yun LI ; Wei SHANG
Journal of Practical Stomatology 2025;41(3):293-304
Oropharyngeal squamous cell carcinoma(OPSCC)is a malignant tumor originating from the squamous epithelium of the oro-pharyngeal mucosa,accounting for more than 90%of oropharyngeal malignancies.In recent years,human papillomavirus(HPV)infec-tion has become one of the primary etiological factors of oropharyngeal squamous carcinoma.The incidence of HPV-associated oropharyn-geal squamous carcinoma has been rising annually,with a noticeable trend toward younger populations,posing a significant threat to hu-man health.Due to the distinct biological behavior and clinical characteristics of HPV-associated oropharyngeal squamous carcinoma com-pared to its non-HPV-related counterpart,the diagnostic and treatment strategies for oropharyngeal squamous carcinoma have undergone substantial changes.Prevention and screening for oropharyngeal squamous carcinoma are of critical importance.The diagnostic and treat-ment process involves multi-disciplinary collaboration,including oral and maxillofacial surgery,otolaryngology,head and neck surgery,oncology,radiology and pathology.Based on evidence from clinical practice,a comprehensive,integrated diagnostic and therapeutic ap-proach has been established,centered around the concept of"prevention,screening,diagnosis,treatment,and rehabilitation",covering the entire patient lifecycle and providing a valuable reference for clinical practice.
5.Expert consensus on holistic integrative management of oral squamous cell carcinoma
Moyi SUN ; Zongxuan HE ; Haoyue XU ; Xiaoying LI ; Jie ZHANG ; Haijun LU ; Xiaohong ZHAN ; Dapeng HAO ; Shizhu BAI ; Wei GUO ; Zhangui TANG ; Guoxin REN ; Jian MENG ; Zhijun SUN ; Jichen LI ; Yue HE ; Chunjie LI ; Lizheng QIN ; Kai YANG ; Qing XI ; Lin KONG ; Bing HAN ; Lingxue BU ; Yuanyong FENG ; Kai SONG ; Hongyu HAN ; Jieying LI ; Qianwei NI ; Yun LI ; Juan CHAI ; Xiaochen YANG ; Man HU ; Mingjin XU ; Wei SHANG
Journal of Practical Stomatology 2025;41(4):437-449
Oral squamous cell carcinoma(OSCC)is a malignant lesion originating from the oral mucosal squamous epithelium,account-ing for over 80%of oral and maxillofacial malignancies.Key etiological factors include tobacco,alcohol abuse,and betel quid chewing.In China,its incidence has shown an overall upward trend,posing a significant threat to public health.OSCC exhibits high local invasive-ness,making early diagnosis critical for improving prognosis.Its clinical management requires close multidisciplinary collaboration among oral and maxillofacial surgery,head and neck surgery,radiation oncology,medical oncology,reconstructive surgery,radiology,patholo-gy,and nutritional support teams.Given the increasing disease burden of OSCC and rapid development of multidisciplinary collaborative models,an expert panel has formulated this integrated management consensus based on evidence-based medicine and extensive deliber-ation.Centered on the'Prevention-Screening-Diagnosis-Treatment-Rehabilitation'framework,the consensus provides comprehensive guidance for the entire disease course of OSCC patients,aiming to standardize clinical practice.
6.Yttrium-90 selective internal radiotherapy in conversion treatment of unresectable hepatocellular carcinoma:research progress
Man ZHAO ; Qianwen NI ; Xianjie PIAO ; Xiaoqin WU ; Rui ZHOU ; Kaiting ZHANG ; Zhenguang WANG ; Minghao ZOU ; Wenxuan ZHOU ; Fuchen LIU ; Hui LIU
Academic Journal of Naval Medical University 2025;46(2):189-197
Yttrium-90(90Y)selective internal radiation therapy(SIRT)is an emerging modality for the treatment of hepatocellular carcinoma(HCC),leveraging the nuclide 90Y to deliver targeted radiation therapy.90Y has a long half-life and can be used to selectively ablate tumor cells by high-energy beta rays.It has high biological effectiveness and robust local control capabilities.In recent years,with the continuous advancement of basic and clinical research,the application of 90Y-SIRT in the conversion treatment of unresectable HCC(uHCC)has made significant progress.However,challenges remain in the clinical application of 90Y-SIRT,including how to improve the efficacy of conversion therapy and how to optimize therapy regimens.This review aims to summarize the research progress of90Y-SIRT in the conversion therapy of uHCC.
7.Analysis of erectile dysfunction and its associated factors in male patients undergoing peritoneal dialysis
Xiaohui XU ; Man ZHANG ; Tingting ZHOU ; Juan NI
National Journal of Andrology 2025;31(10):915-920
Objective To investigate the prevalence proportion and influencing factors of erectile dysfunction in male patients receiving peritoneal dialysis(PD),and to provide a basis for clinical intervention.Methods A total of 170 male patients undergoing maintenance PD in Jinling Hospital from January to June 2025 were selected as the study subjects.And the international erectile function index-5 was used to evaluate sexual function of the patients.The general data,dialy-sis adequacy,nutritional status and other clinical indicators were collected.The logistic regression analysis was used to identify the influence factors of erectile dysfunction in the patients with PD.Results The incidence of erectile dysfunction in male patients with PD was 45.3%.And univariate analysis showed that age,education level,smoking history,dialysis-related symptoms and depressive status were significantly correlated with erectile dysfunction in male patients(all P<0.05).Ordered logistic regression analysis identified age,sleep duration,smoking history,albumin and total cholesterol as independent risk factors for erectile dysfunction in male patients with PD.Conclusion The incidence of erectile dys-function is relatively high in male patients with PD which is influenced by various physiological and psychological factors.Clinically,attention should be paid to patients' nutritional status,sleep quality,and other factors,with comprehensive in-terventions implemented to improve sexual function and overall quality of life.
8.Expert consensus on holistic integrative management of oral squamous cell carcinoma
Moyi SUN ; Zongxuan HE ; Haoyue XU ; Xiaoying LI ; Jie ZHANG ; Haijun LU ; Xiaohong ZHAN ; Dapeng HAO ; Shizhu BAI ; Wei GUO ; Zhangui TANG ; Guoxin REN ; Jian MENG ; Zhijun SUN ; Jichen LI ; Yue HE ; Chunjie LI ; Lizheng QIN ; Kai YANG ; Qing XI ; Lin KONG ; Bing HAN ; Lingxue BU ; Yuanyong FENG ; Kai SONG ; Hongyu HAN ; Jieying LI ; Qianwei NI ; Yun LI ; Juan CHAI ; Xiaochen YANG ; Man HU ; Mingjin XU ; Wei SHANG
Journal of Practical Stomatology 2025;41(4):437-449
Oral squamous cell carcinoma(OSCC)is a malignant lesion originating from the oral mucosal squamous epithelium,account-ing for over 80%of oral and maxillofacial malignancies.Key etiological factors include tobacco,alcohol abuse,and betel quid chewing.In China,its incidence has shown an overall upward trend,posing a significant threat to public health.OSCC exhibits high local invasive-ness,making early diagnosis critical for improving prognosis.Its clinical management requires close multidisciplinary collaboration among oral and maxillofacial surgery,head and neck surgery,radiation oncology,medical oncology,reconstructive surgery,radiology,patholo-gy,and nutritional support teams.Given the increasing disease burden of OSCC and rapid development of multidisciplinary collaborative models,an expert panel has formulated this integrated management consensus based on evidence-based medicine and extensive deliber-ation.Centered on the'Prevention-Screening-Diagnosis-Treatment-Rehabilitation'framework,the consensus provides comprehensive guidance for the entire disease course of OSCC patients,aiming to standardize clinical practice.
9.Correlation analysis of HMGB1 and MCP-1 levels and prognosis of patients with sepsis combined with AKI
Man NI ; Jun GE ; Ziang KONG
Tianjin Medical Journal 2025;53(3):297-301
Objective To analyze the correlation between the levels of high mobility group protein B1(HMGB1),monocyte chemotactic protein-1(MCP-1)and the prognosis of patients with sepsis combined with acute kidney injury(AKI).Methods A total of 100 patients with sepsis combined with AKI treated with continuous renal replacement therapy(CRRT)were included in this study and clinical data before treatment were collected.The levels of HMGB1 and MCP-1 were detected by enzyme-linked immunosorbent assay before and after CRRT treatment.Follow-up began on the day after the end of CRRT treatment,and the end point of follow-up was death or survival within 30 days.Patients were divided into the death group(31 cases)and the survival group(69 cases)according to survival status.Cox regression was used to analyze the relationship between HMGB1 and MCP-1 and death within 30 days after CRRT in patients with septic AKI.Receiver operating characteristics(ROC)curve was used to analyze the prognostic value of HMGB1 and MCP-1 in patients with sepsis combined with AKI after CRRT.Resluts The sequential organ failure(SOFA)scores,acute physiology and chronic healthⅡ(APACHE Ⅱ)scores were lower in the survival group than those in the death group(P<0.05).After CRRT treatment,HMGB1 and MCP-1 levels were lower in the survival group than those in the death group(P<0.05).Cox regression analysis showed that SOFA score,APACHE Ⅱscore,HMGB1 and MCP-1 increase after treatment were risk factors for death in patients with sepsis complicated with AKI.ROC curve analysis showed that the AUC of SOFA score,APACHE Ⅱ score,combined diagnosis of HMGB1 and MCP-1 after treatment was 0.973,which was significantly higher than that of single detection(P<0.05).Conclusion The increased levels of HMGB1 and MCP-1 in peripheral blood after treatment are independent risk factors for 30-day death in patients with sepsis complicated with AKI after CRRT treatment,and the combined prognostic value is high.
10.Expert consensus on holistic integrative management of oropharyngeal squamous cell carcinoma
Moyi SUN ; Zongxuan HE ; Qianwei NI ; Xiaoying LI ; Lin KONG ; Qing XI ; Wei GUO ; Zhangui TANG ; Guoxin REN ; Zhijun SUN ; Jian MENG ; Jie ZHANG ; Jichen LI ; Yue HE ; Chunjie LI ; Lizheng QIN ; Kai YANG ; Bing HAN ; Yan SUN ; Haijun LU ; Xiaohong ZHAN ; Dapeng HAO ; Kai SONG ; Haoyue XU ; Lingxue BU ; Jieying LI ; Man HU ; Mingjin XU ; Yun LI ; Wei SHANG
Journal of Practical Stomatology 2025;41(3):293-304
Oropharyngeal squamous cell carcinoma(OPSCC)is a malignant tumor originating from the squamous epithelium of the oro-pharyngeal mucosa,accounting for more than 90%of oropharyngeal malignancies.In recent years,human papillomavirus(HPV)infec-tion has become one of the primary etiological factors of oropharyngeal squamous carcinoma.The incidence of HPV-associated oropharyn-geal squamous carcinoma has been rising annually,with a noticeable trend toward younger populations,posing a significant threat to hu-man health.Due to the distinct biological behavior and clinical characteristics of HPV-associated oropharyngeal squamous carcinoma com-pared to its non-HPV-related counterpart,the diagnostic and treatment strategies for oropharyngeal squamous carcinoma have undergone substantial changes.Prevention and screening for oropharyngeal squamous carcinoma are of critical importance.The diagnostic and treat-ment process involves multi-disciplinary collaboration,including oral and maxillofacial surgery,otolaryngology,head and neck surgery,oncology,radiology and pathology.Based on evidence from clinical practice,a comprehensive,integrated diagnostic and therapeutic ap-proach has been established,centered around the concept of"prevention,screening,diagnosis,treatment,and rehabilitation",covering the entire patient lifecycle and providing a valuable reference for clinical practice.

Result Analysis
Print
Save
E-mail